Azithromycin Therapy Does Not Reduce Recurrent Wheeze After RSV
Azithromycin therapy during RSV bronchiolitis does not reduce the risk for post-RSV recurrent wheeze over two to four years
Physician’s Briefing Weekly Coronavirus Roundup
Black Patients Still Underrepresented in Trials for New Drug Approvals
No improvement seen in representation of Black patients after implementation of a 2015 FDA action plan to improve diversity
Higher BMI Linked to Improved Lung Function in Cystic Fibrosis
Patients with normal weight have increased odds for CF-related diabetes and exocrine pancreatic insufficiency versus overweight patients
Survival High With ECMO for Selected Severe COVID-19 Patients
Of 30 patients, 90 percent survived to discharge; survival was 86.7 percent at median follow-up of 10.8 months since ECMO cannulation
Interim Estimate Suggests Flu Shot Not Effective in 2021-2022 Season
Vaccine effectiveness against medically attended outpatient acute respiratory infection associated with A(H3N2) was 16 percent
Biden Administration Says California Can Set Tough Auto Emission Standards Again
Several other states are moving to adopt the California standards
Continued Dexamethasone at Discharge Not Tied to Better COVID-19 Outcomes
No association seen with reduced 14-day all-cause readmission or mortality for individuals continuing dexamethasone at discharge
Exhaustion-Related Burnout Higher in Underrepresented Medical Students
However, medical students who are underrepresented in medicine less likely to report disengagement
Congenital Heart Defect May Up Risk for Critical COVID-19 Illness
Among patients with congenital heart defects, critical COVID-19 outcomes linked to having comorbidities, male sex, age 50 to 64 years
